Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes by Nichole E. Brunton, Waldemar E. Wysokinski, David O. Hodge, Danielle T. Vlazny, Damon E. Houghton, Ana I. Casanegra

Get full text

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation by Waldemar E. Wysokinski, MD, PhD, Rowlens M. Melduni, MD, MPH, Naser M. Ammash, MD, Danielle T. Vlazny, PA-C, MS, Ewa Konik, MD, Rayya A. Saadiq, DO, Izabela Gosk-Bierska, MD, Joshua Slusser, BS, Diane Grill, MS, Robert D. McBane, MD

Get full text

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism by Julia C. Cambron, BS, Elias S. Saba, BS, Robert D. McBane, MD, Ana I. Casanegra, MD, Hector R. Villarraga, MD, Damon E. Houghton, MD, Danielle T. Vlazny, PA-C, MS, David Froehling, MD, David Hodge, MS, Lisa G. Peterson, MAN, RN, Dalene M. Bott-Kitslaar, APRN, CNP, Waldemar E. Wysokinski, MD, PhD

Get full text